Abellio London reduces collisions through Mobileye Safety Trial
The trial is supported by Transport for London (TfL) through a grant from its Bus Safety Innovation Fund.
Focused on reducing bus collisions with cyclists, motorcycles, pedestrians and other road users, the trial's findings to date show the Mobileye collision avoidance technology has reduced avoidable collisions by 29% and reduced injuries from such collisions by 60%.
“All over the world, bus companies are investing in Mobileye technology to improve safety standards, ensuring that drivers can take prompt action when danger is detected. Abellio takes safety very seriously, and they've been a superb partner, helping their drivers get the very best out of the system,” said Gil Ayalon, Director of EMEA at Mobileye.
Abellio London's safety technology trial is employing Mobileye's aftermarket collision avoidance technology, which is engineered by the same team developing some of the world's most sophisticated advanced driver assistance systems (ADAS) and autonomous vehicle technology. The solution can be retrofitted to almost any vehicle already on the road. For bus drivers, in particular, the Mobileye system provides critical audio and visual alerts that assist in preventing or mitigating collisions.
Features include Forward Collision Warning, Pedestrian and Cyclist Collision Warning, Headway Monitoring and Warning, Lane Departure Warning, Speed Limit Indicator and Traffic Sign Recognition.
Abellio London operates 48 bus routes across London and runs more than 740 vehicles. For the trial, 66 buses on three of the company's London routes have been equipped with Mobileye collision avoidance technology, each having a camera unit installed on the inside of the windshield and a display placed in the driver's cab. The final results of the trial should be available by the end of this year.
Abellio London reduces collisions through Mobileye Safety Trial
Modified on Friday 16th November 2018
Find all articles related to:
Abellio London reduces collisions through Mobileye Safety Trial